Reference : Insuline glargine et cancer: une tempete dans un verre d'eau?
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
Insuline glargine et cancer: une tempete dans un verre d'eau?
[en] Insulin glargine and cancer: a storm in a glass of water?
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Lefebvre, Pierre [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Revue Médicale de Liège
Hopital de Baviere
Yes (verified by ORBi)
[en] Insulin analogues ; Observational studies ; Insulin glargine ; Cancer
[en] Insulin glargine is widely used as basal insulin in the treatment of type 1 and type 2 diabetes mellitus. However, this insulin analogue has been recently suspected to be associated with an increased risk of cancer, especially breast cancer, in patients with type 2 diabetes. The present article aims at briefly presenting the state of the art based upon currently available data. We will first summarize the observations reported in recent publications, then we will present a critical analysis of these in fact non-conclusive findings, and finally we will conclude with some practical recommendations.
Researchers ; Professionals ; Students

File(s) associated to this reference

Fulltext file(s):

Open access
200909_04.pdfPublisher postprint331.19 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.